Clever Leaves to Present at the 2022 ICR Conference
07 Januar 2022 - 2:30PM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”
or the “Company”), a leading multinational operator and licensed
producer of pharmaceutical-grade cannabinoids, is scheduled to
participate in the 2022 ICR Conference, which is being held
virtually from January 10-12, 2022.
Clever Leaves management is scheduled to present
on Monday, January 10th at 8:30am ET. The presentation will be
webcast live and available for replay here and via the Events
section of the Company’s website here.
To receive additional information, request an
invitation or schedule a one-on-one meeting with Clever Leaves
management, please contact your ICR representative or the Company’s
investor relations team at CLVR@gatewayir.com.
About Clever Leaves Holdings
Inc.
Clever Leaves is a multinational cannabis
company with an emphasis on ecologically sustainable, large-scale
cultivation and pharmaceutical-grade cannabinoid processing as the
cornerstones of its global cannabis business. With operations and
investments in the United States, Canada, Colombia, Germany and
Portugal, Clever Leaves has created an effective distribution
network and global footprint, with a foundation built upon capital
efficiency and rapid growth. Clever Leaves aims to be one of the
industry’s leading global cannabis companies recognized for its
principles, people, and performance while fostering a healthier
global community. Clever Leaves has received multiple international
certifications that have enabled it to increase its export and
sales capacity from its Colombian operations, including European
Union Good Manufacturing Practices (EU GMP) Certification, a Good
Manufacturing Practices (GMP) Certification by Colombia National
Food and Drug Surveillance Institute - Invima, and Good
Agricultural and Collecting Practices (GACP) Certification. Clever
Leaves was granted a license in Portugal from INFARMED – the
Portuguese health authority – which allows Clever Leaves to
cultivate, import and export dry flower for medicinal and research
purposes. In addition, the Portuguese operation was also granted
certification of compliance with GACP and IMC-GAP. For more
information, visit https://cleverleaves.com/en/home/ and follow
Clever Leaves on Twitter and LinkedIn.
Clever Leaves Investor
Inquiries:Cody Slach or Jackie KeshnerGateway Investor
Relations+1-949-574-3860CLVR@gatewayir.com
Clever Leaves Press
Contacts:McKenna MillerKCSA Strategic
Communications+1-347-487-6197mmiller@kcsa.com
Diana SigüenzaStrategic Communications
Director+57-310-236-8830diana.siguenza@cleverleaves.com
Clever Leaves Commercial
Inquiries:Andrew MillerVice President Sales - EMEA, North
America, and
Asia-Pacific+1-416-817-1336andrew.miller@cleverleaves.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024